It was shown that activated CD8+ T cells secrete IFNγ during immunotherapy, which down-regulates the expression of SLC7A11 (as well as its regulatory partner SLC3A2) and subsequently inhibits cystine uptake in cancer cells, thereby augmenting lipid peroxidation and ferroptosis. The gene discussed is CD8A; the disease is cancer.